Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China

References

• Zhang M-X, Zhang T-T, Shi G-F, Cheng F-M, Zheng Y-M, Tung T-H, Chen H-X. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China. Expert Rev Vaccines. 2021;20:1–7. doi:10.1080/14760584.2021.1925112.
   PubMed Web of Science ®Google Scholar
• Habas K, Nganwuchu C, Shahzad F, Gopalan R, Haque M, Rahman S, Majumder AA, Nasim T. Resolution of coronavirus disease 2019 (COVID-19). Expert Rev Anti Infect Ther. 2020;18:1201–1211. doi:10.1080/14787210.2020.1797487.
   PubMed Web of Science ®Google Scholar
• Guidry JPD, Laestadius LI, Vraga EK, Miller CA, Perrin PB, Burton CW, Ryan M, Fuemmeler BF, Carlyle KE. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am J Infect Control. 2021;49:137–142. doi:10.1016/j.ajic.2020.11.018.
   PubMed Web of Science ®Google Scholar
• Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Sci. 2020;369:77–81. doi:10.1126/science.abc1932.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, Xu W, Zhao Y, Li N, Zhang J, et al. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell. 2020;182:713–21 e9. doi:10.1016/j.cell.2020.06.008.
   PubMed Web of Science ®Google Scholar
• He S, and Anderson ET. Conceptualizing and measuring pathways for how object attachment affects willingness to pay (WTP). Curr Opin Psychol. 2021 June;39:121–124. doi:10.1016/j.copsyc.2020.09.008.
   PubMed Web of Science ®Google Scholar
• Shih H-C, Chou P, Chen S-J, Liu J-H, Lee F-L, Liu C-M, Tung T-H. A community-based study of the willingness to pay associated with screening for diabetic retinopathy among type 2 diabetes in Kinmen, Taiwan. J Epidemiol. 2007;17:186–193. doi:10.2188/jea.17.186.
   PubMed Web of Science ®Google Scholar
• Miller KH, Hofstetter R, Krohmer H, Zhang ZJ. How should consumers’ willingness to pay be measured? an empirical comparison of state-of-the-art approaches. J Marketing Res. 2011;48(1):172–184. doi:10.1509/jmkr.48.1.172.
   Web of Science ®Google Scholar
• American Academy of Pediatrics Committee on Infectious Diseases: Universal hepatitis B immunization. Pediatrics. 1992;89: 795–800.
   PubMed Web of Science ®Google Scholar
• Gay NJ, Orenstein WA. The theory of measles elimination: implications for the design of elimination strategies. J Infect Dis. 2004;189(Suppl Supplement_1):S27–35. doi:10.1086/381592.
   PubMedGoogle Scholar
• Naaber P, Tserel L, Kangro K, Sepp E, Jurjenson V, Adamson A, Haljasmägi L, Rumm AP, Maruste R, Kärner J, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet Reg Health - Eur. 2021;10:100208. doi:10.1016/j.lanepe.2021.100208.
   PubMedGoogle Scholar
• Tung TH, Lin XQ, Chen Y, Zhang MX, and Zhu JS. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. Expert Rev Vaccines. 2022 Feb;21(2):261–267. doi: 10.1080/14760584.2022.2016401.
   PubMed Web of Science ®Google Scholar
• Han K, Francis MR, Zhang R, Wang Q, Xia A, Lu L, Yang B, and Hou Z. Confidence, acceptance and willingness to pay for the COVID-19 vaccine among migrants in Shanghai, China: A cross-sectional study. Vaccines (Basel). 2021 May;9(5):443. doi: 10.3390/vaccines9050443.
   Web of Science ®Google Scholar
• Tung TH, Lin XQ, Chen Y, Wu H, Zhang MX, and Zhu JS. Why do parents willingness-to-pay to vaccinate their children against COVID-19? A real-world evidence in Taizhou, China. Hum Vaccin Immunother. 2022 Dec 31;18(1):1–9. doi:10.1080/21645515.2021.2014731.
   PubMed Web of Science ®Google Scholar
• Hou Z, Jie C, Yue D, Fang H, Meng Q, and Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine. 2014 July 31;32(35):4471–4477. doi:10.1016/j.vaccine.2014.06.047.
   PubMed Web of Science ®Google Scholar
• Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Vo TQ, et al. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Human Vaccines Immunotherapeutics. 2020;16:3074–3080. doi:10.1080/21645515.2020.1819741.
   PubMed Web of Science ®Google Scholar
• Wang J, Lyu Y, Zhang H, Jing R, Lai X, Feng H, Knoll MD, Fang H. Willingness to pay and financing preferences for COVID-19 vaccination in China. Vaccine. 2021;39(14):1968–1976. doi:10.1016/j.vaccine.2021.02.060.
   PubMed Web of Science ®Google Scholar
• Apisarnthanarak A, Nantapisal S, Pienthong T, Apisarnthanarak P, and Weber DJ. Healthcare-Associated transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among Thai healthcare personnel who receive 2 doses of a coronavirus disease 2019 (COVID-19) vaccine: A call for considering a booster dose. Infect Control Hosp Epidemiol. 2021 Aug 6:1–2. doi:10.1017/ice.2021.365.
   Google Scholar
• Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021;385:585–594. doi:10.1056/NEJMoa2108891.
   PubMed Web of Science ®Google Scholar
• Adaval RW, Wyer RS. Conscious and nonconscious comparisons with price anchors: effects on willingness to pay for related and unrelated products. J Marketing Res. 2011;48(2):355–365. doi:10.1509/jmkr.48.2.355.
   Web of Science ®Google Scholar
• Dinh Thu H, Nguyen Thanh H, Hua Thanh T, Nguyen Hai L, Tran Thi V, Nguyen Manh T, Buvé A. Mothers’ willingness to pay for daughters’ HPV vaccine in northern Vietnam. Health Care Women Int. 2018;39:450–462. doi:10.1080/07399332.2017.1411914.
   PubMed Web of Science ®Google Scholar
• Umeh IB, Nduka SO, and Ekwunife OI. Mothers’ willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study. Cost Eff Resour Alloc. 2016 Jun 6;14:8. doi:10.1186/s12962-016-0057-0.
   PubMed Web of Science ®Google Scholar
• Ngorsuraches S, Nawanukool K, Petcharamanee K, and Poopantrakool U. Parents’ preferences and willingness-to-pay for human papilloma virus vaccines in Thailand. J Pharm Policy Pract. 2015 Jul 22;8(1):20. doi: 10.1186/s40545-015-0040-8.
   PubMedGoogle Scholar
• Lai X, Zhu H, Wang J, Huang Y, Jing R, Lyu Y, Zhang H, Feng H, Guo J, and Fang H. Public perceptions and acceptance of COVID-19 booster vaccination in China: A cross-sectional study. Vaccines (Basel). 2021 Dec 10;9(12):1461. doi:10.3390/vaccines9121461.
   Web of Science ®Google Scholar
• Kaplan RM, and Milstein A. Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance. Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2021726118. doi: 10.1073/pnas.2021726118.
   Web of Science ®Google Scholar
• Kerekes S, Ji M, Shih SF, Chang HY, Harapan H, and Rajamoorthy Y, et al. Differential effect of vaccine effectiveness and safety on COVID-19 vaccine acceptance across socioeconomic groups in an international sample. Vaccines (Basel). 2021 Sep 11;9(9):1010. doi:10.3390/vaccines9091010.
   PubMed Web of Science ®Google Scholar